Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
VYLEESI prescribing information
The Y2 receptor is involved in anorexigenic responses (suppression of appetite) whereas the Y1 and Y5 receptors have been shown to induce orexigenic responses (stimulation of appetite)
Some disease-specific studies have used approximately 25 mg/kg per day
60.1% 1 More likely to be female 64.9% vs
Acknowledgments During the preparation of this manuscript, the author(s) used BioRender software for making figures
Sources Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies Diabetes, Obesity and Metabolism, Neeland et al., 2024 Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss
US$ 24.06
US$ 24.87
US$ 27.36
US$ 24.64
US$ 21.03
